Ledger.Open graph →
SEC Form D · Amendment · filed July 17, 2025

Renibus Therapeutics, Inc

Offering
$110.9M
Sold
$110.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTHLAKE, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Carlos Guillem · Southlake, TXDirectorGeorge Quinoy · Woburn, MAExec · DirectorD'Ambrosio Trent · Murray, UTExec · DirectorVincent Gubitosi · Newton, MADirectorSelim Dogguy · Chicago, ILDirectorPavel Mucha · Chicago, ILExec · DirectorLara A. Cumberland · Cincinnati, OHExec · DirectorD. J. Keyser · Southlake, TXExec · DirectorChristopher N. Richardson · Minneapolis, MNExecHenrik J. Rasmussen · Southlake, TXDirectorKevin Thueson · Cheyenne, WYDirectorBrian J. Palmer · Fort Worth, TXDirectorJamie J. Donadio · Southlake, TXExecTheodore J. Moskovitz · Austin, TXExecBhupinder J. Singh · Southlake, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗